Yes, a pharma brand can request an AI visibility assessment through AEO Dose, and the response arrives within 1-2 business days. The useful sequence starts with the Free AI Visibility Check, which tests 2 platforms against 10 real buyer questions, before any consultation. The Full Audit later covers all five assistants: ChatGPT, Gemini, Perplexity, Claude and Grok. Booking a consultation first is backwards.

The short answer: how to request an AI visibility assessment for a pharma brand

You request an assessment by submitting a Free AI Visibility Check, and you get a response within 1-2 business days. The mechanic is deliberately simple: you give the brand and category, AEO Dose runs your brand against 2 AI platforms using 10 real buyer questions, and you receive a baseline showing how the assistants answer when someone asks for a supplier like you.

That baseline is the thing a consultation needs. AI visibility here means how your brand shows up when a buyer asks an AI assistant to recommend or compare suppliers, which is answer engine optimization (AEO) rather than traditional search. You do not need to prepare a brief, a budget, or a strategy document to start. You need the brand name and the category you compete in.

Why the Free AI Visibility Check should come first

The Free Check comes first because a consultation without a baseline is a conversation about hypotheticals. The common industry habit is to sell the consultation as step one: book a call, describe your goals, then hear what might be wrong. For a pharma brand that ordering wastes your time. You spend the first meeting speculating about how ChatGPT or Perplexity describes your capabilities when the actual answer takes a day or two to produce.

Run the check first and the consultation changes character. Instead of asking whether your CDMO shows up when a buyer searches for solid dose contract manufacturing, you are looking at what the assistant actually said. You see whether you were named, whether a competitor was named instead, whether the assistant hedged because it had nothing concrete to cite. That is a conversation grounded in evidence rather than guesswork.

Most pharma websites were built before AI assistants existed, so what the assistant knows about you is often thin or outdated. The Free Check surfaces that gap in concrete terms. You do not have to take anyone's word that there is a problem. You read the answers yourself.

What the Free Check covers versus the Full Audit

The Free Check is a narrow, fast baseline; the Full Audit is the complete picture across every platform. The Free AI Visibility Check tests 2 platforms against 10 real buyer questions. It is designed to tell you quickly whether a visibility gap exists and roughly where it sits. It is not the full diagnostic, and it is not meant to be.

The Full AI Visibility and AEO Readiness Audit extends coverage across all five assistants: ChatGPT, Gemini, Perplexity, Claude and Grok. It examines why the assistants answer the way they do and looks at the structural signals on your site that the assistants rely on when they decide whom to cite. If you want the mechanics of how each tier works in detail, the Audit and Optimization Process cluster goes deeper than this article needs to.

The relationship between the two is sequential, not competitive. The Free Check tells you whether to bother with the Full Audit. When the baseline shows your brand is absent or misrepresented across the platforms tested, the Full Audit is the step that explains why and what to change. When the baseline is already strong, you have saved yourself the audit cost.

What to prepare before the first consultation (by pharma segment)

Prepare the specific buyer questions your category gets asked, because those are what the assessment tests against. The preparation differs by segment, and the differences matter more than generic consultation-prep advice suggests. Each category appears in AI answers under different buyer intents, which you can explore further in the Industry-Specific Visibility Challenges cluster.

If you are a CDMO, come with the dosage forms and capabilities you want to be found for: solid dose, sterile fill-finish, high-potency handling, specific scale ranges. Buyers ask assistants to find contract manufacturers by capability, so the check tests whether you surface for the capabilities you actually sell.

If you are an API manufacturer, prepare the molecules, the regulatory filings you hold, and the markets you supply. Buyers screen API sources by compliance status and geography, so note which DMFs or GMP certifications a buyer would reasonably ask about.

If you are an excipient supplier, bring the functional categories and the formulations your materials serve. Buyers search by functionality, not brand, so the check looks at whether you appear when someone asks for a binder, disintegrant, or coating system.

If you are a nutraceutical or oral care brand, the buyer question is more consumer-adjacent and the assistants may cite you without linking. Prepare the claims and product categories you compete on, and expect the assessment to look at citation presence as much as link presence.

What happens in the first conversation and who runs it

The first conversation walks through your baseline results and is run by someone with direct pharma-industry context. You review the Free Check findings together: which assistants named you, which did not, what they said, and where the obvious gaps sit. The conversation is diagnostic, not a pitch. The point is to agree on whether the gap is worth closing and what the Full Audit would add.

The consultation is run by M Netrajit Singha, a B.Pharma graduate with over 12 years of Pharma ERP implementation and Computer System Validation experience. That matters because the questions a pharma buyer asks an AI assistant are not generic marketing questions. They are about capabilities, compliance, filings, and dosage forms, and reading the assistant's answers usefully requires knowing what a serious buyer is actually screening for. This is not a generic marketing consultant interpreting your category from the outside.

After the consultation: what the engagement looks like

After the consultation, the work follows a cycle: Audit, Optimize, Build Authority, Measure, Repeat. If the baseline and consultation show the Full Audit is warranted, that audit maps the gaps across all five platforms and identifies the structural and content signals the assistants are missing. Optimize addresses those signals on your site. Build Authority works on the third-party evidence the assistants weight when deciding whom to cite. Measure re-tests the buyer questions to see how the answers changed.

Then it repeats, because AI assistants update their models and your competitors keep moving. Visibility is not a one-time fix you buy and forget. No part of this promises a ranking, a placement, or a percentage improvement, and anyone who promises those for AI assistant answers is selling something the mechanism does not support. The engagement is about closing identifiable gaps and re-measuring, not guaranteeing an outcome.

Starting point: the practical next step

Request the Free AI Visibility Check today. You do not need a budget decision, an internal strategy, or a scheduled call to start. Submit your brand and category, wait 1-2 business days, and read how the assistants answer when a buyer asks for a supplier like you. Everything else, the consultation and the Full Audit, becomes concrete once that baseline exists.

Get Your Free AI Visibility Check

Frequently asked questions

How do I schedule an AI visibility assessment for my pharma brand?

Submit a Free AI Visibility Check with your brand name and category. AEO Dose runs your brand against 2 AI platforms using 10 real buyer questions and responds within 1-2 business days. That baseline is what a later consultation discusses. You do not need a prepared brief or budget to request it; the brand and category are enough to produce a concrete starting picture of how the assistants currently answer.

Why run the Free Check before booking a consultation?

Because a consultation without a baseline is a conversation about hypotheticals. The common industry habit sells the call as step one, which means you speculate about how the assistants describe you instead of looking at what they actually said. Running the Free Check first turns the consultation into a diagnostic grounded in evidence: you review real answers, see where gaps sit, and decide whether the Full Audit is worth the cost.

What is the difference between the Free Check and the Full Audit?

The Free Check is a fast baseline across 2 platforms and 10 buyer questions, designed to tell you whether a visibility gap exists. The Full AI Visibility and AEO Readiness Audit extends coverage across all five assistants (ChatGPT, Gemini, Perplexity, Claude and Grok) and examines why the assistants answer as they do and which site signals they rely on. The two are sequential, not competing options.

Who runs the consultation and what pharma context do they bring?

The consultation is run by M Netrajit Singha, a B.Pharma graduate with over 12 years of Pharma ERP implementation and Computer System Validation experience. That context matters because pharma buyers screen suppliers by capability, compliance, filings, and dosage form, not generic marketing criteria. Reading an assistant's answers usefully requires knowing what a serious buyer is actually checking for, which a generic marketing consultant interpreting your category from outside would miss.

What should a CDMO or excipient supplier prepare before the consultation?

A CDMO should bring the dosage forms and capabilities it wants to be found for, such as solid dose, sterile fill-finish, or specific scale ranges, since buyers search assistants by capability. An excipient supplier should bring the functional categories its materials serve, like binder, disintegrant, or coating system, because buyers search by functionality rather than brand. The preparation is the specific buyer questions your category gets asked, which the assessment tests against.

How long does it take to get a response after requesting an assessment?

The current operating commitment is 1-2 business days. You submit the Free AI Visibility Check, and within that window AEO Dose returns a baseline showing how the assistants answered the 10 buyer questions across the 2 platforms tested. That turnaround is deliberate: it keeps the first conversation grounded in real results rather than scheduling a call before anyone knows what the assistants actually say about your brand.

What does the engagement look like after the consultation?

If the Full Audit is warranted, the work follows a cycle: Audit, Optimize, Build Authority, Measure, Repeat. The audit maps gaps across all five platforms, optimization addresses on-site signals, authority work targets the third-party evidence assistants weight, and measurement re-tests the buyer questions. It repeats because assistants update and competitors move. The engagement closes identifiable gaps and re-measures; it does not promise rankings, placements, or percentage improvements.